Knockdown of USF2 inhibits pyroptosis of podocytes and attenuates kidney injury in lupus nephritis
- PMID: 37341818
- DOI: 10.1007/s10735-023-10135-8
Knockdown of USF2 inhibits pyroptosis of podocytes and attenuates kidney injury in lupus nephritis
Abstract
As an essential factor in the prognosis of Systemic lupus erythematosus (SLE), lupus nephritis (LN) can accelerate the rate at which patients with SLE can transition to chronic kidney disease or even end-stage renal disease (ESRD). Proteinuria due to decreased glomerular filtration rate following podocyte injury is LN's most common clinical manifestation. Podocyte pyroptosis and related inflammatory factors in its process can promote lupus to involve kidney cells and worsen the occurrence and progression of LN, but its regulatory mechanism remains unknown. Accumulating evidence has shown that upstream stimulatory factor 2 (USF2) plays a vital role in the pathophysiology of kidney diseases. In this research, multiple experiments were performed to investigate the role of USF2 in the process of LN. USF2 was abnormally highly expressed in MRL/lpr mice kidney tissues. Renal function impairment and USF2 mRNA levels were positively correlated. Silencing of USF2 in MRL/lpr serum-stimulated cells significantly reduced serum-induced podocyte pyroptosis. USF2 enhanced NLRP3 expression at the transcriptional level. Silencing of USF2 in vivo attenuated kidney injury in MRL/lpr mice, which suggests that USF2 is important for LN development and occurrence.
Keywords: Lupus nephritis; Podocyte injury; Pyroptosis; Upstream stimulatory factor 2.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis.Front Immunol. 2021 Nov 19;12:720877. doi: 10.3389/fimmu.2021.720877. eCollection 2021. Front Immunol. 2021. PMID: 34867948 Free PMC article.
-
C/EBPβ isoform-specific regulation of podocyte pyroptosis in lupus nephritis-induced renal injury.J Pathol. 2023 Nov;261(3):269-285. doi: 10.1002/path.6174. Epub 2023 Aug 21. J Pathol. 2023. PMID: 37602503
-
Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation.Inflammation. 2024 Apr;47(2):649-663. doi: 10.1007/s10753-023-01935-x. Epub 2023 Dec 12. Inflammation. 2024. PMID: 38085465
-
Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches.Semin Arthritis Rheum. 2017 Apr;46(5):632-641. doi: 10.1016/j.semarthrit.2016.10.005. Epub 2016 Oct 17. Semin Arthritis Rheum. 2017. PMID: 27839739 Review.
-
Immune podocytes in the immune microenvironment of lupus nephritis (Review).Mol Med Rep. 2023 Nov;28(5):204. doi: 10.3892/mmr.2023.13091. Epub 2023 Sep 15. Mol Med Rep. 2023. PMID: 37711069 Free PMC article. Review.
Cited by
-
The Onset of Systemic Lupus Erythematosus Triggers Nucleus Pulposus Cell Pyroptosis to Exacerbate Intervertebral Disc Degeneration.J Inflamm Res. 2024 Oct 25;17:7705-7719. doi: 10.2147/JIR.S486297. eCollection 2024. J Inflamm Res. 2024. PMID: 39473981 Free PMC article.
-
Transcription Factors in the Pathogenesis of Lupus Nephritis and Their Targeted Therapy.Int J Mol Sci. 2024 Jan 16;25(2):1084. doi: 10.3390/ijms25021084. Int J Mol Sci. 2024. PMID: 38256157 Free PMC article. Review.
References
-
- Amy H, Chan, Kate Schroder (2020) Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med 217(1):e20190314. https://doi.org/10.1084/jem.20190314 - DOI
-
- Anadi Mahajan J, Amelio K, Gairy G, Kaur, Roger A, Levy D, Roth, Damon B (2020) Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus 29(9):1011–1020. https://doi.org/10.1177/0961203320932219 - DOI - PubMed - PMC
-
- Andrew S, Bomback, Glen S, Markowitz (2016) Lupus Podocytopathy: a distinct entity. Clin J Am Soc Nephrology: CJASN 11(4):547–548. https://doi.org/10.2215/CJN.01880216 - DOI
-
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, David Wofsy (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78(9):1151–1159. https://doi.org/10.1136/annrheumdis-2018-214819 - DOI - PubMed
-
- Austin HA 3rd, Lr M, Km J, Balow Je (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25(4):689–695. https://doi.org/10.1038/ki.1984.75 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials